{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:15:16Z","timestamp":1780341316871,"version":"3.54.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urolithiasis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Oxalate is a toxic waste product in humans, capable of complexing with calcium to form kidney stones. While some oxalate is consumed in the diet, there are endogenous sources in humans. This review compiles known endogenous sources of urinary oxalate. PubMed and Embase databases were searched, as well as backward citations, for relevant articles published in English. The search strategy relied on terms related to endogenous synthesis and metabolic tracing. Title\/abstract review was performed, and articles were excluded from full review if they did not report data on human sources of endogenous oxalate. Risk of bias was assessed using a modified JBI checklist. Weighted averaging was used to combine results and predict endogenous oxalate production. Of 228 unique articles identified, 23 were eligible and included in this study. Total endogenous oxalate production was reported by 7 of the papers, representing 305 healthy subjects. Weighted mean of endogenous oxalate production was 23.8\u00a0mg\/day (95% CI 23\u201324.6\u00a0mg\/day) with a range of 17\u201334\u00a0mg\/day. Daily turnover from the metabolic pool of ascorbic acid may account for up to 40% \u2212\u200960% of total endogenous oxalate production. Other contributors include hydroxyproline (~\u200915%), glycine (&lt;\u200910%), and glycolate (~\u20094%). Phenylalanine (&lt;\u20090.7%), and fructose (negligible) contribute minimally. This review highlights that daily turnover from the metabolic pool of ascorbic acid is the primary source of endogenous oxalate. However, current estimates rely on highly variable data dating back nearly 70 years. Future research using modern metabolomics is required to re-characterize this pathway.<\/jats:p>","DOI":"10.1007\/s00240-026-01995-2","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T10:55:53Z","timestamp":1777546553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Where does endogenous oxalate come from? - a systematic review of endogenous sources of urinary oxalate"],"prefix":"10.1007","volume":"54","author":[{"given":"Brian","family":"Dick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Mena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall","family":"Stoller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"1995_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00240-020-01210-w","volume":"49","author":"A Chewcharat","year":"2021","unstructured":"Chewcharat A, Curhan G (2021) Trends in the prevalence of kidney stones in the United States from 2007 to 2016. Urolithiasis 49:27\u201339. https:\/\/doi.org\/10.1007\/s00240-020-01210-w","journal-title":"Urolithiasis"},{"key":"1995_CR2","unstructured":"Alan W, Partin MD (2020) Campbell Walsh Wein Urology, 12th ed"},{"key":"1995_CR3","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/sj.ki.5002708","volume":"73","author":"GC Curhan","year":"2008","unstructured":"Curhan GC, Taylor EN (2008) 24-h uric acid excretion and the risk of kidney stones. Kidney Int 73:489\u2013496. https:\/\/doi.org\/10.1038\/sj.ki.5002708","journal-title":"Kidney Int"},{"key":"1995_CR4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1046\/j.1523-1755.2001.00488.x","volume":"59","author":"RP Holmes","year":"2001","unstructured":"Holmes RP, Goodman HO, Assimos DG (2001) Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 59:270\u2013276. https:\/\/doi.org\/10.1046\/j.1523-1755.2001.00488.x","journal-title":"Kidney Int"},{"key":"1995_CR5","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.juro.2014.05.006","volume":"192","author":"MS Pearle","year":"2014","unstructured":"Pearle MS, Goldfarb DS, Assimos DG et al (2014) Medical management of kidney stones: AUA guideline. J Urol 192:316\u2013324. https:\/\/doi.org\/10.1016\/j.juro.2014.05.006","journal-title":"J Urol"},{"key":"1995_CR6","doi-asserted-by":"publisher","first-page":"e1230","DOI":"10.1002\/cl2.1230","volume":"18","author":"NR Haddaway","year":"2022","unstructured":"Haddaway NR, Page MJ, Pritchard CC, McGuinness LA (2022) PRISMA2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis. Campbell Syst Rev 18:e1230. https:\/\/doi.org\/10.1002\/cl2.1230","journal-title":"Campbell Syst Rev"},{"key":"1995_CR7","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3109\/00365528109181987","volume":"16","author":"B Nordenvall","year":"1981","unstructured":"Nordenvall B, Backman L, Larsson L (1981) Oxalate metabolism after intestinal bypass operations. Scand J Gastroenterol 16:395\u2013399. https:\/\/doi.org\/10.3109\/00365528109181987","journal-title":"Scand J Gastroenterol"},{"key":"1995_CR8","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/ajcn\/65.5.1453","volume":"65","author":"M Liebman","year":"1997","unstructured":"Liebman M, Chai W (1997) Effect of dietary calcium on urinary oxalate excretion after oxalate loads. Am J Clin Nutr 65:1453\u20131459. https:\/\/doi.org\/10.1093\/ajcn\/65.5.1453","journal-title":"Am J Clin Nutr"},{"key":"1995_CR9","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/S0022-5347(05)67680-X","volume":"163","author":"M Liebman","year":"2000","unstructured":"Liebman M, Costa G (2000) Effects of calcium and magnesium on urinary oxalate excretion after oxalate loads. J Urol 163:1565\u20131569","journal-title":"J Urol"},{"key":"1995_CR10","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1053\/j.ajkd.2004.08.028","volume":"44","author":"W Chai","year":"2004","unstructured":"Chai W, Liebman M, Kynast-Gales S, Massey L (2004) Oxalate absorption and endogenous oxalate synthesis from ascorbate in calcium oxalate stone formers and non-stone formers. Am J Kidney Dis 44:1060\u20131069. https:\/\/doi.org\/10.1053\/j.ajkd.2004.08.028","journal-title":"Am J Kidney Dis"},{"key":"1995_CR11","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s00345-005-0028-0","volume":"23","author":"DJ Zimmermann","year":"2005","unstructured":"Zimmermann DJ, Hesse A, von Unruh GE (2005) Influence of a high-oxalate diet on intestinal oxalate absorption. World J Urol 23:324\u2013329. https:\/\/doi.org\/10.1007\/s00345-005-0028-0","journal-title":"World J Urol"},{"key":"1995_CR12","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/s0022-5347(05)01001-3","volume":"175","author":"S Voss","year":"2006","unstructured":"Voss S, Hesse A, Zimmermann DJ et al (2006) Intestinal oxalate absorption is higher in idiopathic calcium oxalate stone formers than in healthy controls: measurements with the [(13)C2]oxalate absorption test. J Urol 175:1711\u20131715. https:\/\/doi.org\/10.1016\/s0022-5347(05)01001-3","journal-title":"J Urol"},{"key":"1995_CR13","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1681\/asn.0000000000000176","volume":"34","author":"S Fargue","year":"2023","unstructured":"Fargue S, Wood KD, Crivelli JJ et al (2023) Endogenous Oxalate Synthesis and Urinary Oxalate Excretion. J Am Soc Nephrol 34:1505\u20131507. https:\/\/doi.org\/10.1681\/asn.0000000000000176","journal-title":"J Am Soc Nephrol"},{"key":"1995_CR14","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1177\/08927790251360011","volume":"39","author":"S Fargue","year":"2025","unstructured":"Fargue S, Knight J, Maalouf NM et al (2025) Factors Influencing Oxalate Synthesis in Healthy Volunteers. J Endourol 39:815\u2013821. https:\/\/doi.org\/10.1177\/08927790251360011","journal-title":"J Endourol"},{"key":"1995_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1159\/000280341","volume":"35","author":"M Butz","year":"1980","unstructured":"Butz M, Hoffmann H, Kohlbecker G (1980) Dietary influence on serum and urinary oxalate in healthy subjects and oxalate stone formers. Urol Int 35:309\u2013315. https:\/\/doi.org\/10.1159\/000280341","journal-title":"Urol Int"},{"key":"1995_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000282562","volume":"52","author":"RG Hahn","year":"1994","unstructured":"Hahn RG, Sikk M (1994) Glycine loading and urinary oxalate excretion. Urol Int 52:14\u201316. https:\/\/doi.org\/10.1159\/000282562","journal-title":"Urol Int"},{"key":"1995_CR17","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.metabol.2010.09.002","volume":"60","author":"J Knight","year":"2011","unstructured":"Knight J, Assimos DG, Callahan MF, Holmes RP (2011) Metabolism of primed, constant infusions of [1,2-13C\u2082] glycine and [1-13C\u2081] phenylalanine to urinary oxalate. Metabolism 60:950\u2013956. https:\/\/doi.org\/10.1016\/j.metabol.2010.09.002","journal-title":"Metabolism"},{"key":"1995_CR18","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1038\/sj.ki.5001906","volume":"70","author":"J Knight","year":"2006","unstructured":"Knight J, Jiang J, Assimos DG, Holmes RP (2006) Hydroxyproline ingestion and urinary oxalate and glycolate excretion. Kidney Int 70:1929\u20131934. https:\/\/doi.org\/10.1038\/sj.ki.5001906","journal-title":"Kidney Int"},{"key":"1995_CR19","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1681\/asn.2017040390","volume":"29","author":"S Fargue","year":"2018","unstructured":"Fargue S, Milliner DS, Knight J et al (2018) Hydroxyproline Metabolism and Oxalate Synthesis in Primary Hyperoxaluria. J Am Soc Nephrol 29:1615\u20131623. https:\/\/doi.org\/10.1681\/asn.2017040390","journal-title":"J Am Soc Nephrol"},{"key":"1995_CR20","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1681\/asn.2021060729","volume":"32","author":"SF Garrelfs","year":"2021","unstructured":"Garrelfs SF, van Harskamp D, Peters-Sengers H et al (2021) Endogenous Oxalate Production in Primary Hyperoxaluria Type 1 Patients. J Am Soc Nephrol 32:3175\u20133186. https:\/\/doi.org\/10.1681\/asn.2021060729","journal-title":"J Am Soc Nephrol"},{"key":"1995_CR21","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1055\/s-0030-1265145","volume":"42","author":"J Knight","year":"2010","unstructured":"Knight J, Assimos DG, Easter L, Holmes RP (2010) Metabolism of fructose to oxalate and glycolate. Horm Metab Res 42:868\u2013873. https:\/\/doi.org\/10.1055\/s-0030-1265145","journal-title":"Horm Metab Res"},{"key":"1995_CR22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.7326\/0003-4819-101-3-405_2","volume":"101","author":"CS Tsao","year":"1984","unstructured":"Tsao CS (1984) Ascorbic Acid Administration and Urinary Oxalate. Ann Intern Med 101:405\u2013406. https:\/\/doi.org\/10.7326\/0003-4819-101-3-405_2","journal-title":"Ann Intern Med"},{"key":"1995_CR23","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/s0022-5347(17)37521-3","volume":"147","author":"M Urivetzky","year":"1992","unstructured":"Urivetzky M, Kessaris D, Smith AD (1992) Ascorbic acid overdosing: a risk factor for calcium oxalate nephrolithiasis. J Urol 147:1215\u20131218. https:\/\/doi.org\/10.1016\/s0022-5347(17)37521-3","journal-title":"J Urol"},{"key":"1995_CR24","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/s0022-5347(17)35100-5","volume":"151","author":"TR Wandzilak","year":"1994","unstructured":"Wandzilak TR, D\u2019Andre SD, Davis PA, Williams HE (1994) Effect of high dose vitamin C on urinary oxalate levels. J Urol 151:834\u2013837. https:\/\/doi.org\/10.1016\/s0022-5347(17)35100-5","journal-title":"J Urol"},{"key":"1995_CR25","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.metabol.2008.09.023","volume":"58","author":"L Robitaille","year":"2009","unstructured":"Robitaille L, Mamer OA, Miller WH et al (2009) Oxalic acid excretion after intravenous ascorbic acid administration. Metabolism 58:263\u2013269. https:\/\/doi.org\/10.1016\/j.metabol.2008.09.023","journal-title":"Metabolism"},{"key":"1995_CR26","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/01.ju.0000076001.21606.53","volume":"170","author":"O Traxer","year":"2003","unstructured":"Traxer O, Huet B, Poindexter J et al (2003) Effect of ascorbic acid consumption on urinary stone risk factors. J Urol 170:397\u2013401. https:\/\/doi.org\/10.1097\/01.ju.0000076001.21606.53","journal-title":"J Urol"},{"key":"1995_CR27","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1046\/j.1523-1755.2003.00815.x","volume":"63","author":"AC Baxmann","year":"2003","unstructured":"Baxmann AC, De OGMC, Heilberg IP (2003) Effect of vitamin C supplements on urinary oxalate and pH in calcium stone-forming patients. Kidney Int 63:1066\u20131071. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00815.x","journal-title":"Kidney Int"},{"key":"1995_CR28","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1177\/0148607104028006435","volume":"28","author":"L de la Pe\u00f1a","year":"2004","unstructured":"de la Pe\u00f1a L, Lieske JC, Milliner D et al (2004) Urinary oxalate excretion increases in home parenteral nutrition patients on a higher intravenous ascorbic acid dose. JPEN J Parenter Enter Nutr 28:435\u2013438. https:\/\/doi.org\/10.1177\/0148607104028006435","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"1995_CR29","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/S0021-9258(18)70515-2","volume":"230","author":"L Hellman","year":"1958","unstructured":"Hellman L, Burns JJ (1958) Metabolism of L-ascorbic acid-1-C14 in man. J Biol Chem 230:923\u2013930","journal-title":"J Biol Chem"},{"key":"1995_CR30","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1093\/clinchem\/30.3.467","volume":"30","author":"RH Ng","year":"1984","unstructured":"Ng RH, Menon M, Ladenson JH (1984) Collection and handling of 24-hour urine specimens for measurement of analytes related to renal calculi. Clin Chem 30:467\u2013471","journal-title":"Clin Chem"},{"key":"1995_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0009-8981(97)00070-3","volume":"264","author":"HS Brand","year":"1997","unstructured":"Brand HS, J\u00f6rning GGA, Chamuleau RAFM, Abraham-Inpijn L (1997) Effect of a protein-rich meal on urinary and salivary free amino acid concentrations in human subjects. Clin Chim Acta 264:37\u201347. https:\/\/doi.org\/10.1016\/S0009-8981(97)00070-3","journal-title":"Clin Chim Acta"},{"key":"1995_CR32","doi-asserted-by":"publisher","first-page":"571","DOI":"10.7326\/0003-4819-101-4-571_2","volume":"101","author":"H Posner","year":"1984","unstructured":"Posner H (1984) Ascorbic Acid and Urinary Oxalate. Ann Intern Med 101:571\u2013572. https:\/\/doi.org\/10.7326\/0003-4819-101-4-571_2","journal-title":"Ann Intern Med"},{"key":"1995_CR33","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1093\/clinchem\/31.10.1703","volume":"31","author":"AH Chalmers","year":"1985","unstructured":"Chalmers AH, Cowley DM, McWhinney BC (1985) Stability of ascorbate in urine: relevance to analyses for ascorbate and oxalate. Clin Chem 31:1703\u20131705","journal-title":"Clin Chem"},{"key":"1995_CR34","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1093\/clinchem\/36.9.1642","volume":"36","author":"M Petrarulo","year":"1990","unstructured":"Petrarulo M, Marangella M, Bianco O et al (1990) Preventing ascorbate interference in ion-chromatographic determinations of urinary oxalate: four methods compared. Clin Chem 36:1642\u20131645","journal-title":"Clin Chem"},{"key":"1995_CR35","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1016\/S0021-9258(18)93840-8","volume":"239","author":"GL Atkins","year":"1964","unstructured":"Atkins GL, Dean BM, Griffin WJ, Watts RW (1964) QUANTITATIVE ASPECTS OF ASCORBIC ACID METABOLISM IN MAN. J Biol Chem 239:2975\u20132980","journal-title":"J Biol Chem"},{"key":"1995_CR36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/ajcn\/12.1.21","volume":"12","author":"AF Abt","year":"1963","unstructured":"Abt AF, Von Schuching S, Enns T (1963) Vitamin C requirements of man re-examined. New values based on previously unrecognized exhalatory excretory pathway of ascorbic acid. Am J Clin Nutr 12:21\u201329. https:\/\/doi.org\/10.1093\/ajcn\/12.1.21","journal-title":"Am J Clin Nutr"}],"container-title":["Urolithiasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00240-026-01995-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00240-026-01995-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00240-026-01995-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T10:55:53Z","timestamp":1777546553000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00240-026-01995-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1995"],"URL":"https:\/\/doi.org\/10.1007\/s00240-026-01995-2","relation":{},"ISSN":["2194-7236"],"issn-type":[{"value":"2194-7236","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"16 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"No ethical approval was required for this systematic review as no human participants were directly involved.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics Approval"}}],"article-number":"98"}}